If the SD BIOLINE Dengue IgG/IgM RDT were used as directed, individuals with primary DENV immunity, who are at high risk of future dengue disease and may benefit most from vaccination, would rarely test positive and receive the vaccine (6, 33). The gene discussed is CD40LG; the disease is dengue disease.